Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lynn Crismon

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
The Annals of Pharmacotherapy|August 10, 2006
Clinical psychopharmacology: advances and challenges from 1965 to 2006M Lynn Crismon
Child Welfare|August 6, 2009
The use of psychotropic medication for children in foster careM Lynn Crismon, Tami Argo
Frontiers in Psychiatry|February 16, 2026
Real-world effectiveness and safety of xanomeline and trospium for treatment-resistant schizophrenia in a state hospital systemNina Vadiei, M Lynn Crismon
Drugs & Aging|April 25, 2003
Drug interactions with cholinesterase inhibitorsJennifer L Defilippi, M Lynn Crismon
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Economic evaluation of citalopram use and expenditures among recipients in the Texas Medicaid programMichael T Johnsrud, M Lynn Crismon
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 2, 2003
Evaluation of a schizophrenia medication algorithm in a state hospitalWei-Chung Chuang, M Lynn Crismon
Pharmacotherapy|February 18, 2003
A survey of herbal use in children with attention-deficit-hyperactivity disorder or depressionSuzanne Cala, M Lynn Crismon, Jennifer Baumgartner
The Annals of Pharmacotherapy|January 26, 2006
Diagnoses and antipsychotic treatment among youths in a public mental health systemNick C Patel, M Lynn Crismon, Alan Shafer
The Journal of Behavioral Health Services & Research|October 11, 2005
Rehospitalization rates of patients with bipolar disorder discharged on a mood stabilizer versus a mood stabilizer plus an atypical or typical antipsychoticNick C Patel, M Lynn Crismon, Michael Pondrom
Advances in Neurobiology|March 17, 2023
Drug Development for New Psychiatric Drug TherapiesM Lynn Crismon, Janet Walkow, Roger W Sommi
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
The Annals of Pharmacotherapy|August 10, 2006
Clinical psychopharmacology: advances and challenges from 1965 to 2006M Lynn Crismon
Child Welfare|August 6, 2009
The use of psychotropic medication for children in foster careM Lynn Crismon, Tami Argo
Frontiers in Psychiatry|February 16, 2026
Real-world effectiveness and safety of xanomeline and trospium for treatment-resistant schizophrenia in a state hospital systemNina Vadiei, M Lynn Crismon
Drugs & Aging|April 25, 2003
Drug interactions with cholinesterase inhibitorsJennifer L Defilippi, M Lynn Crismon
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Economic evaluation of citalopram use and expenditures among recipients in the Texas Medicaid programMichael T Johnsrud, M Lynn Crismon
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 2, 2003
Evaluation of a schizophrenia medication algorithm in a state hospitalWei-Chung Chuang, M Lynn Crismon
Pharmacotherapy|February 18, 2003
A survey of herbal use in children with attention-deficit-hyperactivity disorder or depressionSuzanne Cala, M Lynn Crismon, Jennifer Baumgartner
The Annals of Pharmacotherapy|January 26, 2006
Diagnoses and antipsychotic treatment among youths in a public mental health systemNick C Patel, M Lynn Crismon, Alan Shafer
The Journal of Behavioral Health Services & Research|October 11, 2005
Rehospitalization rates of patients with bipolar disorder discharged on a mood stabilizer versus a mood stabilizer plus an atypical or typical antipsychoticNick C Patel, M Lynn Crismon, Michael Pondrom
Advances in Neurobiology|March 17, 2023
Drug Development for New Psychiatric Drug TherapiesM Lynn Crismon, Janet Walkow, Roger W Sommi
Pageof 8